1.
Khan K. Clinical Evaluation of Pioglitazone’s Impact on Insulin Resistance and Blood Pressure in Type 2 Diabetic Patients Undergoing Hemodialysis. IJMBS [Internet]. 2025 Jan. 30 [cited 2026 Apr. 27];9(1):241-6. Available from: https://www.ijmbs.info/index.php/ijmbs/article/view/3063